Patent Application
20130111631
The present invention relates to means and methods for altering the activity of the 3-Deoxy-D-Arabino-Heptulosonate 7-Phosphate (DAHP) Synthase in plants leading to increased production of the Shikimate pathway derived primary and secondary metabolites, including aromatic amino acids.
The shikimate pathway, present in many organisms including plants, links metabolism of carbohydrates to biosynthesis of aromatic compounds. In a sequence of several metabolic steps, primary carbon is converted via shikimate into chorismate, (upper part of
The first committed enzyme of the Shikimate pathway is 3-Deoxy-D-Arabino-Heptulosonate 7-Phosphate Synthase (DAHPS), which converts hosphoenolpyruvate (PEP) and Erythrose 4-Phosphate (E-4P) into 3-Deoxy-D-Arabino-Heptulosonate 7-Phosphate (DAHP) (
European Patent No. 1270721 discloses recombinant DNA sequences encoding feedback inhibition released enzymes, particularly a mutated AroG gene encoding 3-deoxy-D-arabinoheptulonic acid-7-phosphate synthase, wherein the proline residue 150 is substituted by a leucine residue, plasmids containing these recombinant DNA sequences, microorganisms transformed with these plasmids, and a process for preparing L-tryptophan, L-phenylalanine and L-tyrosine by fermentation.
In contrast to E. coli and many other bacterial species, the allosteric regulation of plant DAHPS is still questionable. (Gilchrist, D. and T. Kosuge, In: B. N. Miflin, ed, the Biochemistry of Plants, Academic Press, New York, 1980. 5:507-531; Herrmann, K. M. and L. M. Weaver, Annu Rev Plant Physiol Plant Mol Biol, 1999. 50:473-503). It has been described that the in vitro activities of DAHPS from different plant species may be weakly inhibited by Trp and Tyr or weakly activated by either Trp or Tyr. In addition, the activity of the bean (Vigna radiate) DAHPS is weakly inhibited by prephenate and arogenate, the precursors of Phe and Tyr biosynthesis. It is still unknown, however, whether this feedback is due to inhibition of the enzyme expression or inhibition of its activity.
Arabidopsis plants possess two DAHPS genes, DHS1 (At4G39980) and DHS2 (At4G33510) in addition to one putative gene (At1g22410) with high similarity to DHS1. The expression of DHS1 in Arabidopsis is induced by physical wounding or by infiltration with pathogenic Pseudomonas syringae strains (Keith, B. et al., Proc Natl Acad Sci USA, 1991. 88(19):8821-8825). The presence of amino-terminal extensions characteristic of chloroplast transit peptides in the Arabidopsis proteins encoded by DHS1 and DHS2 supports the notion that both proteins are localized in the chloroplast. Tomato (Solanum esculentum) also contains two distinct DHAPS encoding genes that contain plastid transit peptides and are differentially expressed (Gorlach, J. et al., Plant Mol Biol, 1993. 23(4):707-16). Nevertheless, despite the available information on DAHPS expression and activity in plants, it is still unknown whether this enzyme serves as a major regulator of the flux through the Shikimate pathway and hence whether DAHPS is a key regulatory enzyme bridging between primary and secondary metabolism.
U.S. Pat. No. 5,906,925 discloses methods for increasing the yield of 3-deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) in microorganisms through genetic alterations, particularly by overexpression of phosphoenol pyruvate synthase.
U.S. Pat. No. 6,911,331 discloses isolated nucleic acid fragment encoding a DAHP synthetase. The patent also discloses the construction of a chimeric gene encoding all or a portion of the DAHP synthetase, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the DAHP synthetase in a transformed host cell, including plant cell.
U.S. Pat. No. 5,776,736 discloses the enzymes 3-dehydroquinate synthase, shikimate kinase, 5-enolpyruvoyl-Shikimate-3-phosphate synthase and chorismate synthase as rate-limiting enzymes in the common pathway of aromatic amino acid biosynthesis in prokaryotes. Transforming prokaryotic cells with exogenous DNA sequences encoding these enzymes resulted in a significant increase in the end product production.
U.S. Pat. No. 7,790,431 discloses enzymes and enzymatic pathways for the pyruvate-based synthesis of shikimate or at least one intermediate thereto or derivative thereof. The patent also discloses nucleic acids encoding the enzymes, cells transformed therewith, and kits containing said enzymes, cells, or nucleic acid. A KDPGa1 aldolase is used to perform condensation of pyruvate with D-erythrose 4-phosphate to form 3-deoxy-D-arabino-heptulosonate-7-phosphate (DAHP); a 3-dehydroquinate synthase is used to convert the DAHP to 3-dehydroquinate (DHQ); DHQ dehydratase can then convert DHQ to the key shikimate intermediate, 3-dehydroshikimate.
International (PCT) Application Publication No. WO 2009/072118 to the inventors of the present invention discloses that transforming plant cells with polynucleotide(s) encoding feedback-insensitive chorismate mutase and prephenate dehydrates results in altered content of at least one of the aromatic amino acids phenylalanine, tyrosine and tryptophan. However, these enzymes are located downstream the Shikimate pathway, and thus the amount of available chorismate is a “bottle neck” dictating the maximum levels of aromatic acids that may be produced.
Thus, means for modulation of the Shikimate pathway in plants towards the production of increased rates of the aromatic amino acids phenylalanine, tyrosine and tryptophan is highly desired, as these amino acids are both essential components of protein synthesis and also serve as precursors for a wide range of secondary metabolites that are important for plant growth as well as for human nutrition and health.
The present invention now discloses that attenuating the feedback inhibition of 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase (DHAPS), the first enzyme of the Shikimate pathway in plants, triggers the accumulation of the direct products of the Shikimate pathway and of the aromatic amino acid phenylalanine. Levels of tryptophan and tyrosine are also increased, albeit to somewhat lesser extent compared to the level of phenylalanine.
The present invention is based in part on the unexpected finding that expression in a plant cell of the E. coli mutant AroG gene, encoding DAHPS having reduced sensitivity to feedback inhibition by phenylalanine (also referred to herein as “feedback insensitive DAHPS”), resulted in overproduction of the aromatic amino acids phenylalanine, tryptophan and tyrosine. Without wishing to be bound by any specific theory or mechanism of action, the observed increase in the aromatic amino acid contents can be attributed to overproduction of shikimate and/or chorismate, which release the “bottle neck” in the production of chorismate-derived secondary metabolites as well as of phenylalanine, tryptophan and tyrosine. One advantage of the teachings of the present invention relies upon the regulation of one of the first rate-limiting enzymes in the Shikimate pathway, such that the amount of precursor metabolites is increased. Having elevated amounts of the precursor metabolites enable the production of secondary metabolites at elevated amounts.
Thus, according to one aspect, the present invention provides a transgenic plant comprising at least one plant cell comprising an exogenous polynucleotide encoding 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase (DAHPS) having a reduced sensitivity to feedback inhibition, wherein the transgenic plant comprises an increased amount of at least one of an aromatic amino acid, shikimate, chorismate or a catabolic product thereof compared to a corresponding non transgenic plant.
According to certain embodiments, the transgenic plant comprises an increased amount of at least one aromatic amino acid selected from the group consisting of phenylalanine, tyrosine, tryptophan or a combination thereof compared to a corresponding non transgenic plant.
According to other embodiments, the transgenic plant comprises an increased amount of phenylalanine compared to a corresponding non transgenic plant. According to further embodiments, the transgenic plant comprises an increased amount of tyrosine compared to a corresponding non transgenic plant. According to yet further embodiments, the transgenic plant comprises an increased amount of tryptophan compared to a corresponding non transgenic plant. According to additional embodiments, the transgenic plant comprises an increase amount of prephenate compared to a corresponding non transgenic plant.
According to other embodiments, the transgenic plant comprises an increased amount of at least one catabolic product of the aromatic amino acids compared to the corresponding non transgenic plant. According to certain embodiment, the catabolic product is a phenylpropanoid selected from the group consisting of lignin, chlorogenic acid (3-Caffeoylquinate), flavonoid and benzeniod.
According to yet further embodiments, the transgenic plant comprises an increased amount of shikimate, or catabolic products thereof compared to a corresponding non transgenic plant.
According to certain embodiments, the polynucleotide encodes a bacterial DAHPS. According to certain typical embodiments, the polynucleotide encodes E. coli DAHPS isoenzyme. According to certain currently typical embodiments, the polynucleotide encodes E. coli AroG DAHPS having a reduced sensitivity to feedback inhibition by phenylalanine.
According to certain embodiments, the feedback insensitive E. coli AroG DAHPS has at least one point mutation at a position selected from the group consisting of position 150, 175, 179 and 209 of the wild type E. coli AroG DAHPS, having the amino acid sequence set forth in SEQ ID NO:1 (NCBI accession number AAA23492).
According to certain embodiments, proline at position 150 is replaced by leucine (P150L). According to other embodiments, the leucine at position 175 is replaced by glutamine (L175Q). According to further embodiments, leucine at position 179 is replaced by aspartate (L179D). According to yet additional embodiments the phenylalanine at position 209 is replaced by alanine (F209A).
According to certain currently typical embodiments, the AroG DAHPS enzyme has a reduced sensitivity to feedback inhibition by phenylalanine, and the polynucleotide is selected from a polynucleotide encoding AroG DAHPS having the mutation L175Q (designated hereinafter AroG175) having the amino acid sequence set forth in SEQ ID NO:2 and a polynucleotide encoding AroG DAHPS having the mutation F209A (designated hereinafter AroG209) having the amino acid sequence set forth in SEQ ID NO:4. According to these embodiments, the polynucleotide is selected from the group consisting of a polynucleotide comprising the nucleic acid sequence set forth in SEQ ID NO:3 and a polynucleotide comprising the nucleic acid sequence set forth in SEQ ID NO:5.
The inventors of the present invention have previously disclosed that a significant portion of the synthesis of phenylalanine products in a plant cell occurs within the cell plastids. Thus, according to certain embodiments, the polynucleotides encoding the feedback insensitive AroG DAHPS further comprises a nucleic acid sequence encoding a plastid transit peptide. According to these embodiments, the polynucleotide encoding the plastid transit peptide comprises a nucleic acid sequence as set forth in SEQ ID NO:6. Typically, the polynucleotides are so designed that the encoded plastid transit peptide is fused at the amino terminus of the encoded polypeptide.
According to yet other embodiments, the polynucleotides of the present invention are incorporated in a DNA construct enabling their expression in the plant cell. According to one embodiment, the DNA construct comprises at least one expression regulating element selected from the group consisting of a promoter, an enhancer, an origin of replication, a transcription termination sequence, a polyadenylation signal and the like.
According to some embodiments, the DNA construct comprises a promoter. The promoter can be constitutive, induced or tissue specific promoter as is known in the art. According to typical embodiments, the promoter is a constitutive promoter operable in a plant cell. According to another embodiment, the DNA construct further comprises transcription termination and polyadenylation sequence signals.
Optionally, the DNA construct further comprises a nucleic acid sequence encoding a detection marker enabling a convenient detection of the recombinant polypeptides expressed by the plant cell. According to certain embodiments, the DNA construct further comprises a nucleic acid sequence encoding three repeats of hemagglutinin (HA) epitope tag. This epitope allows the detection of the recombinant polypeptide by using antibodies raised against the HA epitope tag, said tag having the nucleic acid sequence set forth in SEQ ID NO:7. According to one embodiment, the DNA construct comprises a nucleic acid sequence encoding a polypeptide containing the pea rbcS3 plastid transit peptide, L175Q AroG DAHPS and three repeats of the HA epitope tag, said polypeptide having SEQ ID NO:8. According to another embodiment, the DNA construct comprises a nucleic acid sequence encoding a polypeptide containing the pea rbcS3 plastid transit peptide, F209A AroG DAHPS and three repeats of the HA epitope tag, said polypeptide having SEQ ID NO:9.
The polynucleotides of the present invention and/or the DNA constructs comprising same can be incorporated into a plant transformation vector.
It is to be understood explicitly that the scope of the present invention encompasses homologs, analogs, variants and derivatives, including shorter and longer polypeptides, proteins and polynucleotides, as well as polypeptide, protein and polynucleotide analogs with one or more amino acid or nucleic acid substitution, as well as amino acid or nucleic acid derivatives, non-natural amino or nucleic acids and synthetic amino or nucleic acids as are known in the art, with the stipulation that these variants and modifications must preserve the DAHPS activity of the polypeptide in the context of the present invention, that is activity which is not sensitive to feedback inhibition and thus leading to accumulation of shikimate-derived and chorismate-derived metabolites as disclosed herein. Specifically, any active fragments of the active polypeptide or protein as well as extensions, conjugates and mixtures are disclosed according to the principles of the present invention.
The present invention also encompasses seeds of the transgenic plant, wherein plants grown from said seeds comprise at least one cell having an altered content of at least one an aromatic amino acid, shikimate, chorismate or catabolic product thereof compared to plants grown from seeds of corresponding non transgenic plant. The present invention further encompasses fruit, leaves or any part of the transgenic plant, as well as tissue cultures derived thereof and plants regenerated therefrom.
According to yet another aspect, the present invention provides a method of inducing the synthesis of at least one of shikimate, chorismate and an aromatic amino acid in a plant, comprising (a) transforming at least one plant cell with an exogenous polynucleotide encoding DAHPS having reduced sensitivity to feedback inhibition and (b) regenerating the at least one transformed cell into a transgenic plant comprising at least one cell having an increased amount of at least one of shikimate, chorismate, an aromatic amino acid and secondary metabolites derived therefrom, compared to a corresponding cell of a non transgenic plant.
According to certain embodiments, the DAHPS has reduced sensitivity to feedback inhibition by phenylalanine. According to other embodiment, the polynucleotide encodes a mutant DAHPS selected from the group consisting of L175Q AroG DAHPS and F209A AroG DAHPS.
The exogenous polynucleotide(s) encoding L175Q or F209A AroG DAHPS according to the teachings of the present invention can be introduced into a DNA construct to include the entire elements necessary for transcription and translation as described above, such that the polypeptides are expressed within the plant cell.
Transformation of plants with a polynucleotide or a DNA construct may be performed by various means, as is known to one skilled in the art. Common methods are exemplified by, but are not restricted to, Agrobacterium-mediated transformation, microprojectile bombardment, pollen mediated transfer, plant RNA virus mediated transformation, liposome mediated transformation, direct gene transfer (e.g. by microinjection) and electroporation of compact embryogenic calli. According to one embodiment, the transgenic plants of the present invention are produced using Agrobacterium mediated transformation.
Transgenic plants comprising the polynucleotides of the present invention may be selected employing standard methods of molecular genetics, as are known to a person of ordinary skill in the art. According to certain embodiments, the transgenic plants are selected according to their resistance to an antibiotic. According to one embodiment, the antibiotic serving as a selectable marker is one of the group consisting of Cefotaxime, Vancomycin and Kanamycin. According to other embodiments, the transgenic plants are selected according to their resistance to an herbicide. According to one embodiment, the herbicide is Glufosinate ammonium (Basta).
According to other aspects the present invention relates to the transgenic plants generated by the methods of the present invention as well as to their seeds, fruit, roots and other organs or isolated parts thereof.
Any plant can be transformed with the polynucleotides of the present invention to produce the transgenic plants having elevated amount of at least one of shikimate, chorismate, an aromatic amino acid and secondary metabolites derived therefrom, compared to the non-transgenic plant. According to certain embodiments, the plant is a crop plant. According to certain typical embodiments, the plant is a tomato plant.
Other objects, features and advantages of the present invention will become clear from the following description and drawings.
The present invention discloses transgenic plants transformed with exogenous nucleic acid encoding 3-deoxy-d-arabino-heptulosonate-7-phosphate synthase (DAHPS) having a reduced sensitivity to feedback inhibition by a product of its activity, the aromatic amino acid phenylalanine, compared to a wild type DAHPS. The present invention shows for the first time that releasing this feedback inhibition in a plant cell results in increased accumulation of shikimate and the aromatic amino acids phenylalanine, tyrosine and tryptophan. Furthermore, the present invention now shows that expression of the feedback-insensitive DAHPS triggers the expression of genes associated with biotic stress, including pathogenesis-related genes, as well as genes associated with cell wall metabolism, secondary metabolism, biotic-stress related hormone metabolism (ethylene as well as salicylic acid that is produced via the Shikimate and Phenylalanine biosynthesis pathways), redox state regulation, transcription factors and signaling genes.
The present invention now shows that transgenic plants expressing the feedback-insensitive DAHPS gene produce increased amount of phenylalanine compared to corresponding non transgenic plants. Moreover, the present invention now shows that the expression of a bacterial DAHPS polypeptide having reduced sensitivity to feedback inhibition in transgenic plants, particularly within the plastid of the plant cell leads to over production of secondary metabolites, which require phenylalanine and/or tyrosine and/or tryptophan and/or intermediate compounds produced through the phenylalanine pathway for their biosynthesis. Particularly, the second metabolites include phenylpropanoids selected from the group consisting of lignin, which is an essential component of the cell wall; chlorogenic acid (3-Caffeoylquinate), an antioxidant and inhibitor of the tumor promoting activity of phorbol esters; and flavonoids, which are plant pigment contributing to plant coloring and UV protection. The alteration of the Shikimate pathway may also lead to the production of phenylpropanoids class of benzeniods, which are volatile compounds essential for sweet, floral and fruity flavors.
The present invention also provides a method of producing transgenic plants having increased amounts of at least one of shikimate, chorismate and an aromatic amino acid selected from the group consisting of phenylalanine, tryptophan and tyrosine as compared to a corresponding non transgenic plant. Also provided by the present invention are plant cells, comprising exogenous nucleic acids encoding DAHPS that is insensitive to feedback inhibition, particularly to feedback inhibition by phenylalanine, and plant seeds and progenies obtained from the transgenic plants.
The present invention makes a significant contribution to the art by providing new strategies to engineer plants having the capability to modify the production of secondary metabolites. The present invention utilizes primary enzymes in the Shikimate pathway, not previously shown to be manipulated in plants by the release of feedback inhibition, for overproduction of shikimate and aromatic amino acids as well as secondary metabolites derived therefrom.
The plants of the present invention are capable of overproducing secondary metabolites that have beneficial effects on the plant characteristics, for example fruit taste and aroma. Furthermore, the plants of the invention overproduce secondary metabolites required for their beneficial characterizations, which are naturally produced by the plant in insufficient amounts to be used commercially.
As used herein, the terms “having reduced sensitivity to feedback inhibition”, “insensitive to feedback inhibition” or “feedback insensitive” with regard to DAHPS activity refer to complete or essential relieve of feedback inhibition at 1 mM of Phe, while showing similar specific enzymatic activity as the wild type (Hu et al. 2003, supra).
The term “plant” is used herein in its broadest sense. It includes, but is not limited to, any species of woody, herbaceous, perennial or annual plant. It also refers to a plurality of plant cells that are largely differentiated into a structure that is present at any stage of a plant's development. Such structures include, but are not limited to, a root, stem, shoot, leaf, flower, petal, fruit, etc.
As used herein, the term “feedback inhibition” refers to a cellular control mechanism of enzyme activity, in which an enzyme that catalyzes the production of a particular substance in the cell is inhibited when that substance has accumulated to a certain level.
The term “phenylalanine catabolic product(s)” refers to classes of plant-derived organic compounds that are biosynthesized from the amino acid phenylalanine, particularly phenylpropanoids. The phenylpropanoids have a wide variety of functions in the plant, including defense against herbivores, microbial attack, or other sources of injury; as structural components of cell walls; as protection from ultraviolet light; as pigments; and as signaling molecules.
The term “3-Deoxy-D-Arabino-Heptulosonate 7-Phosphate Synthase (DAHPS)” as used herein refers to a protein having the enzymatic activity of converting Phosphoenolpyruvate (PEP) and Erythrose 4-Phosphate (E-4P) into 3-Deoxy-d-Arabino-Heptulosonate 7-Phosphate (DAHP) (
The term “gene” refers to a nucleic acid (e.g., DNA or RNA) sequence that comprises coding sequences necessary for the production of RNA or a polypeptide. A polypeptide can be encoded by a full-length coding sequence or by any part thereof. The term “parts thereof” when used in reference to a gene refers to fragments of that gene. The fragments may range in size from a few nucleotides to the entire gene sequence minus one nucleotide. Thus, “a nucleic acid sequence comprising at least a part of a gene” may comprise fragments of the gene or the entire gene.
The term “gene” also encompasses the coding regions of a structural gene and includes sequences located adjacent to the coding region on both the 5′ and 3′ ends for a distance of about 1 kb on either end such that the gene corresponds to the length of the full-length mRNA. The sequences which are located 5′ of the coding region and which are present on the mRNA are referred to as 5′ non-translated sequences. The sequences which are located 3′ or downstream of the coding region and which are present on the mRNA are referred to as 3′ non-translated sequences.
The terms “polynucleotide”, “polynucleotide sequence”, “nucleic acid sequence”, and “isolated polynucleotide” are used interchangeably herein. These terms encompass nucleotide sequences and the like. A polynucleotide may be a polymer of RNA or DNA or hybrid thereof, that is single- or double-stranded, linear or branched, and that optionally contains synthetic, non-natural or altered nucleotide bases. The terms also encompass RNA/DNA hybrids.
An “isolated” nucleic acid molecule is one that is substantially separated from other nucleic acid molecules which are present in the natural source of the nucleic acid (i.e., sequences encoding other polypeptides). Preferably, an “isolated” nucleic acid is free of some of the sequences which naturally flank the nucleic acid (i.e., sequences located at the 5′ and 3′ ends of the nucleic acid) in its naturally occurring replicon. For example, a cloned nucleic acid is considered isolated. A nucleic acid is also considered isolated if it has been altered by human intervention, or placed in a locus or location that is not its natural site, or if it is introduced into a cell by agroinfection. Moreover, an “isolated” nucleic acid molecule, such as a cDNA molecule, can be free from some of the other cellular material with which it is naturally associated, or culture medium when produced by recombinant techniques, or chemical precursors or other chemicals when chemically synthesized.
The term “recombinant” refers to an artificial combination of two otherwise separated segments of sequence, e.g., by chemical synthesis or by the manipulation of isolated segments of nucleic acids by genetic engineering techniques.
The term “construct” as used herein refers to an artificially assembled or isolated nucleic acid molecule which includes the gene of interest. In general a construct may include the gene or genes of interest, a marker gene which in some cases can also be the gene of interest and appropriate regulatory sequences. It should be appreciated that the inclusion of regulatory sequences in a construct is optional, for example, such sequences may not be required in situations where the regulatory sequences of a host cell are to be used. The term construct includes vectors but should not be seen as being limited thereto.
The term “operably linked” refers to the association of nucleic acid sequences on a single nucleic acid fragment so that the function of one is regulated by the other. For example, a promoter is operably linked with a coding sequence when it is capable of regulating the expression of that coding sequence (i.e., that the coding sequence is under the transcriptional control of the promoter). Coding sequences can be operably linked to regulatory sequences in a sense or antisense orientation. In another example, the complementary RNA regions of the invention can be operably linked, either directly or indirectly, 5′ to the target mRNA, or 3′ to the target mRNA, or within the target mRNA, or a first complementary region is 5′ and its complement is 3′ to the target mRNA.
The terms “promoter element,” “promoter,” or “promoter sequence” as used herein, refer to a DNA sequence that is located at the 5′ end (i.e. precedes) the protein coding region of a DNA polymer. The location of most promoters known in nature precedes the transcribed region. The promoter functions as a switch, activating the expression of a gene. If the gene is activated, it is said to be transcribed, or participating in transcription. Transcription involves the synthesis of mRNA from the gene. The promoter, therefore, serves as a transcriptional regulatory element and also provides a site for initiation of transcription of the gene into mRNA. Promoters may be derived in their entirety from a native gene, or be composed of different elements derived from different promoters found in nature, or even comprise synthetic DNA segments. It is understood by those skilled in the art that different promoters may direct the expression of a gene in different tissues or cell types, or at different stages of development, or in response to different environmental conditions. It is further recognized that since in most cases the exact boundaries of regulatory sequences have not been completely defined, DNA fragments of some variation may have identical promoter activity. Promoters which cause a gene to be expressed in most cell types at most times are commonly referred to as “constitutive promoters”. New promoters of various types useful in plant cells are constantly being discovered; numerous examples may be found in Okamuro J K and Goldberg R B (1989) Biochemistry of Plants 15:1-82.
As used herein, the term an “enhancer” refers to a DNA sequence which can stimulate promoter activity, and may be an innate element of the promoter or a heterologous element inserted to enhance the level or tissue-specificity of a promoter.
The term “expression”, as used herein, refers to the production of a functional end-product e.g., an mRNA or a protein.
The term “transgenic” when used in reference to a plant or seed (i.e., a “transgenic plant” or a “transgenic seed”) refers to a plant or seed that contains at least one heterologous transcribeable polynucleotide in one or more of its cells. The term “transgenic plant material” refers broadly to a plant, a plant structure, a plant tissue, a plant seed or a plant cell that contains at least one heterologous polynucleotide in at least one of its cells. A “transgenic plant” and a “corresponding non transgenic plant” as used herein refer to a plant comprising at least one cell comprising a heterologous transcribeable polynucleotide and to a plant of the same type lacking said heterologous transcribeable.
The terms “transformants” or “transformed cells” include the primary transformed cell and cultures derived from that cell regardless to the number of transfers. All progeny may not be precisely identical in DNA content, due to deliberate or inadvertent mutations. Mutant progeny that have the same functionality as screened for in the originally transformed cell are included in the definition of transformants.
Transformation of a cell may be stable or transient. The term “transient transformation” or “transiently transformed” refers to the introduction of one or more exogenous polynucleotides into a cell in the absence of integration of the exogenous polynucleotide into the host cell's genome. Transient transformation may be detected by, for example, enzyme-linked immunosorbent assay (ELISA), which detects the presence of a polypeptide encoded by one or more of the exogenous polynucleotides. Alternatively, transient transformation may be detected by detecting the activity of the protein (e.g. β-glucuronidase) encoded by the exogenous polynucleotide.
The term “transient transformant” refers to a cell which has transiently incorporated one or more exogenous polynucleotides. In contrast, the term “stable transformation” or “stably transformed” refers to the introduction and integration of one or more exogenous polynucleotides into the genome of a cell. Stable transformation of a cell may be detected by Southern blot hybridization of genomic DNA of the cell with nucleic acid sequences which are capable of binding to one or more of the exogenous polynucleotides. Alternatively, stable transformation of a cell may also be detected by enzyme activity of an integrated gene in growing tissue or by the polymerase chain reaction of genomic DNA of the cell to amplify exogenous polynucleotide sequences.
The term “stable transformant” refers to a cell which has stably integrated one or more exogenous polynucleotides into the genomic or organellar DNA. It is to be understood that a plant or a plant cell transformed with the nucleic acids, constructs and/or vectors of the present invention can be transiently as well as stably transformed. The terms “polypeptide,” “peptide” and “protein” are used interchangeably herein to refer to a polymer of amino acid residues. The terms apply to amino acid polymers in which one or more amino acid residue is an artificial chemical analogue of a corresponding naturally occurring amino acid, as well as to naturally occurring amino acid polymers.
According to one aspect, the present invention provides a transgenic plant comprising at least one plant cell comprising an exogenous polynucleotide encoding 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase (DAHPS) having reduced sensitivity to feedback inhibition, wherein the transgenic plant comprises an increased amount of at least one of an aromatic amino acid, shikimate, chorismate or a catabolic product thereof compared to a corresponding non transgenic plant.
According to certain embodiments, the polynucleotide encodes a bacterial DAHPS. According to certain typical embodiments, the polynucleotide encodes feedback insensitive E. coli DAHPS isoenzyme. According to further currently typical embodiments, the polynucleotide comprises E. coli AroG gene encoding a DAHPS having a reduced sensitivity to feedback inhibition.
According to certain embodiments, the E. coli AroG gene encoding the feedback insensitive DAHPS has at least one point mutation at a position selected from the group consisting of position 150, 175, 179 and 209 of the wild type E. coli AroG DAHPS, having the amino acid sequence set forth in SEQ ID NO:1. According to one embodiment, proline at position 150 is replaced by leucine (P150L). According to other embodiments, the leucine at position 175 is replaced by glutamine (L175Q). According to further embodiments, leucine at position 179 is replaced by aspartic acid (L 179D). According to yet additional embodiments the phenylalanine at position 209 is replaced by alanine (F209A).
According to certain currently preferred embodiments, the AroG gene encodes a DAHPS that shows reduced sensitivity to feedback inhibition by phenylalanine. According to these embodiments, the polynucleotide encodes DAHPS having the mutation L175Q (designated hereinafter AroG175). According to one embodiment, the feedback insensitive DAHPS has an amino acid sequence as set forth in SEQ ID NO:2.
According to other currently preferred embodiments, the AroG gene encodes a DAHPS that is insensitive to feedback inhibition by phenylalanine. According to these embodiments, the polynucleotide encodes DAHPS having the mutation F209A (designated hereinafter AroG209). According to one embodiment, the feedback insensitive DAHPS has an amino acid sequence as set forth in SEQ ID NO:4.
According to other currently typical embodiments, the AroG polynucleotide comprises the nucleic acid sequence set forth in any one of SEQ ID NO:3 and SEQ ID NO:5.
Despite the major importance of the aromatic amino acid metabolism in plant primary and secondary production, still very little is known about the regulation of the conversion of primary carbon and nitrogen metabolites via the Shikimate pathway into the biosynthesis of the three aromatic amino acids phenylalanine, tyrosine and tryptophan.
The present invention now shows that Arabidopsis and tomato plants expressing the AroG175 or AroG209 have enhanced levels of the three aromatic amino acids phenylalanine, tyrosine and tryptophan. In Arabidopsis, the levels of phenylalanine and tryptophan were found to be elevated more significantly, while in tomato the increase in the levels of phenylalanine and tyrosine was more prominent. This finding implies that DAHPS is a limiting enzyme that its activity regulates the conversion of primary carbon metabolites via the conversion of chorismate to aromatic amino acids as well as to metabolites that are derived directly from chorismate. Interestingly, among the two aromatic amino acids, phenylalanine accumulation was stimulated to a much higher degree than tryptophan in the AroGj75 expressing Arabidopsis plants (
According to certain embodiments, the transgenic plant comprises an increased amount of at least one aromatic amino acid selected from the group consisting of phenylalanine, tyrosine, tryptophan or a combination thereof compared to a corresponding non transgenic plant. It is to be explicitly understood that each possibility represents a separate embodiment of the present invention.
According to other embodiments, the transgenic plant comprises an increased amount of at least one catabolic product of phenylalanine compared to the corresponding non transgenic plant. According to certain embodiments, the catabolic product of phenylalanine is selected from several classes of metabolites including, but not limited to: terpenoids; glycoalkalodies (dehydrolycoperoside G, F or A); carotenoids (phytoene, phytofluene or lycopene); phenylpropanoids; lignin (caffeate, ferulate); coumarate and caffeoylquinate; flavonoids (Kaempferol, Quercetin derivatives and anthocyanins); phenylalanine derived glucosinolate (2-phenylethyl glucosinolate and phenylacetonitrile); and salicylate derivatives (hydroxybenzoate hexose and dihydroxybenzoate hexose). According to one embodiment, the catabolic product of tyrosine is homogentisate. According to one embodiment, the catabolic product of tryptophan is selected from several classes of metabolites selected from, but not limited to: tryptophan derived glucosinolates (1-(1H-indole-3-carboxylate) glucopyranose, 4-hydroxy-indolyl-3-methyl glucosinolate, 4-methoxyindole glucosinolate, 1-methoxyindole glucosinolate, 4-O-(Indole-3-acetyl)-dihexose); Auxin conjugates (4-O-(Indole-3-acetyl)-dihexose). The present invention further shows that the amount of additional classes of metabolites is elevated in the transgenic plant compared to a corresponding non-transgenic plant, including, but not limited to: monosaccharide (mannose, fructose, guanosine, fructose-6-phosphate); oligosaccharide (maltose, raffinose, trehalose and cellobiose); additional amino acids (glycine, glutamine, threonine, aspargine); polyamines (Putrecine); jasmonate conjugates (12-hydroxy jasmonate-hexose); methionine derived glucosinolates (3-benzoyloxypropyl glucosinolate, 8-methylthiooctyl glucosinolate, 7-methylthioheptyl glucosinolate and methylsulfonyloctyl glucosinolate); and combinations thereof.
The present invention further shows that AroG175 expression triggers a significant increase in the accumulation of shikimate as well as of prephenate, the precursor of phenylalanine biosynthesis (
In Arabidopsis, AroG175 expression increased the levels of a number of phenylalanine-derived secondary metabolites, including lignin precursors and their derivatives, anthocyanins, flavonoids, phenylalanine-derived glucosinolates, tryptophan derived glucosinolate, Methionine derived glucosinolates, Auxin, jasmonate and salicylate conjugates (
In tomato fruit, AroG209 expression increased the levels of a number of phenylalanine-derived secondary metabolites including anthocyanins, flavonoids, coumarate and caffeoylquinate derivatives as well as monosaccharides and oligosaccharides (
Taken together, these results imply the presence of a regulatory cross interaction between the fluxes of the shikimate and aromatic amino acid biosynthesis pathways and their further metabolism into various secondary metabolites. The results also indicate that DAHPS functions as an important regulatory enzyme in the conversion of primary to secondary metabolism in plants. Manipulating the expression of combinations of genes, particularly chorismate mutase, (CM), prephenate dehydratase (PDT) and 3-Deoxy-D-Arabino-Heptulosonate 7-Phosphate Synthase (DAHPS), having reduced sensitivity to feedback inhibition by phenylalanine, may thus result in synergistic effect on the accumulation the aromatic amino acids phenylalanine and tyrosine and metabolites derived thereof.
As is shown in the Examples section hereinbelow, modulation of the DAHPS gene triggers significant expression changes in a moderate number of genes (109 genes). It appears that a considerable subset of these genes could be associated with biotic stresses, including those involved in hormone metabolism (cytokinin, absicisic acid, salicylate and jasmonate), several classes of transcription factors (TF) (MYBs, WRKYs and APETALA2/Ethylene-responsive element binding proteins), transportes, genes involved in signaling (calcium and cytokinin AAR-genes), genes encoding pathogenesis-related (PR) proteins including disease resistance proteins (TIR-NB proteins), and genes involved in redox regulation. These results are concomitant with the results of previous reports showing that pathogen attack and physical wounding stimulate the expression of the endogenous DAHPS genes in various plants, including Arabidopsis (Keith B. et al., 1991. Proceedings of the National Academy of Sciences 88(19):8821-8825), tomato (Gorlach J. et al., 1993. Plant Molecular Biology 23(4): 707-716) and potato (Muday G. K. and K. M. Herrmann, 1992. Plant Physiology 98(2): 496-500; Jones J. D. et al., 1995. Plant Physiology 108(4): 1413-1421). Additional studies also suggested that antisense inhibition of potato DAHPS transcript reduced the lignin content in the cell wall (Jones et al. 1995, supra).
The present invention shows that in the AroG175 genotype, the change in the expression level of genes associated with synthesis of phenylalanine-derived secondary metabolites, including phenylpropanoids and metabolites associated with cell wall and salicylate metabolism correlated with changes in the levels of these classes of metabolites.
Particularly, the levels of indole-glucosinolates, aliphatic-glucosinolates and phenylalanine-glucosinolates were significantly increased in the AroG175 lines in correlation to the increase in the mRNA levels of the following genes: (i) the gene encoding Flavin-Monooxygenase (FMO like glucosinolate s-oxygenase (AT1G65860; 2.1 fold increased) which catalyzes the conversion of methylthioalkyl glucosinolates to methylsulfinylalkyl glucosinolates and (ii) the gene encoding CYP81F2, a cytochrome P450 enzyme (AT5G57220; 2.7 fold increased), involved in indole glucosinolate metabolism. Without wishing to be bound by any specific theory or mechanism of action, the altered transcriptom and metabolome in AroG175 transgenic plants supports a regulatory link between glucosinolate metabolism and the Shikimate pathway.
The expression level of 16 genes, categorized as genes associated with the circadian clock, was also induced in the AroG175-2 transcriptome. These circadian clock-related genes included those encoding MYB transcription factors (At1G01060 and At2G46830) and Zinc Finger DNA-binding proteins that regulate gene expression (At2G31380 and At5G15850). Clusters of circadian-regulated genes were previously found to connect important signaling networks that coordinate plant growth with rhythmic changes in the environment, including auxin, phenylpropanoid biosynthesis and starch metabolism. In addition, by over expression of the PRODUCTION OF ANTHOCYANIN PIGMENT1 (PAP1) transcription factor, which regulates the expression of several genes encoding key flavonoid enzymes, it has been shown that these target genes are regulated by the circadian clock. The co-regulation of PAP1 with the phenylpropanoids biosynthesis genes has also suggested that PAP1 acts as a master regulator of clock-controlled transcription of these genes (Harmer S. L. et al., 2000. Science 290(5499): 2110-2113). Hence, the findings of the present invention support the presence of a novel regulatory link between the expression of genes controlling physiological processes that are associated with the circadian clock and the conversion of primary to secondary metabolites.
Another enriched gene category displaying increased expression was associated with nitrate assimilation, as it included genes encoding a nitrate transporter (At3g21670; NTP3) and two Nitrate Reductases (At1g77760; NIA1 and At1g37130; NIA2). The regulation of nitrogen metabolism is strongly associated with the regulation of glycolysis and the pentose phosphate pathway that serve as the donors of PEP and E-4P, the two substrates of DAHPS (Stitt M., 1999. Current Opinion in Plant Biology 2(3):178-186). In addition, nitrogen metabolism and translocation in plant cells has a major regulatory role in the competition between pathogens and their host plants for nitrogen availability. In the AroG175 transcriptome, genes associated with nitrate assimilation and disease resistance, including genes encoding PR proteins were induced.
Without wishing to be bound by any specific theory or mechanism of action, the results of the present invention suggest that DAHPS activity, and perhaps the activity of other enzymes of the Shikimate pathway, influence the network connecting nitrogen metabolism with pathogen response in Arabidopsis plants.
Several genes putatively encoding transcription factors were down regulated in the AroG175-2 line, including for example Zinc Finger B-box type proteins with a CCT domain (At3G07650, AT5G48250, At1G28050, At3G20810, At 1G07050). The expression of three other genes, encoding proteins associated with the circadian clock cascade, were decreased, including TOC1 (Timing of CAB expression 1; At5G61380), Pseudo-response regulator (At5G60100) and ELF4 (Early flowering 4; At2G40080).
Cloning of a polynucleotide encoding the AroG DAHPS can be performed by any method as is known to a person skilled in the art. Various DNA constructs may be used to express the AroG DAHPS in a desired plant.
The present invention provides a DNA construct or an expression vector comprising a polynucleotide encoding AroG DAHPS, which may further comprise regulatory elements, including, but not limited to, a promoter, an enhancer, and a termination signal.
Among the most commonly used promoters are the nopaline synthase (NOS) promoter (Ebert et al., 1987 Proc. Natl. Acad. Sci. U.S.A. 84:5745-5749), the octapine synthase (OCS) promoter, caulimovirus promoters such as the cauliflower mosaic virus (CaMV) 19S promoter (Lawton et al., 1987 Plant Mol. Biol. 9:315-324), the CaMV 35S promoter (Odell et al., 1985 Nature 313:810-812), and the figwort mosaic virus 35S promoter, the light inducible promoter from the small subunit of rubisco, the Adh promoter (Walker et al., 1987 Proc Natl Aca. Sci U.S.A. 84:6624-66280, the sucrose synthase promoter (Yang et al., 1990 Proc. Natl. Acad. Sci. U.S.A. 87:4144-4148), the R gene complex promoter (Chandler et al., 1989. Plant Cell 1:1175-1183), the chlorophyll a/b binding protein gene promoter, etc. Other commonly used promoters are, the promoters for the potato tuber ADPGPP genes, the sucrose synthase promoter, the granule bound starch synthase promoter, the glutelin gene promoter, the maize waxy promoter, Brittle gene promoter, and Shrunken 2 promoter, the acid chitinase gene promoter, and the zein gene promoters (15 kD, 16 kD, 19 kD, 22 kD, and 27 kD; Perdersen et al. 1982 Cell 29:1015-1026). A plethora of promoters is described in International Patent Application Publication No. WO 00/18963. According to certain currently preferred embodiments, the construct of the present invention comprises the constitutive CaMV 35S promoter or the E8 promoter (Deikman J. et al., Plant Physiol 100:2013-2017)
The “3′ non-coding sequences” refer to DNA sequences located downstream of a coding sequence and include polyadenylation recognition sequences and other sequences encoding regulatory signals capable of affecting mRNA processing or gene expression. The polyadenylation signal is usually characterized by affecting the addition of polyadenylic acid tracts to the 3′ end of the mRNA precursor. The use of different 3′non-coding sequences is exemplified by Ingelbrecht 1 L et al. (1989. Plant Cell 1:671-680).
In particular embodiments of the present invention, the following elements were used to assemble the DNA constructs of the present invention:
The above described sequences are used as regulatory elements that enable the expression of the encoding nucleic acid sequence within a plant cell.
Those skilled in the art will appreciate that the various components of the nucleic acid sequences and the transformation vectors described in the present invention are operatively linked, so as to result in expression of said nucleic acid or nucleic acid fragment. Techniques for operatively linking the components of the constructs and vectors of the present invention are well known to those skilled in the art. Such techniques include the use of linkers, such as synthetic linkers, for example including one or more restriction enzyme sites.
According to yet another aspect, the present invention provides a method of inducing the synthesis of at least one of shikimate, chorismate and an aromatic amino acid in a plant, comprising (a) transforming a plant cell with an exogenous polynucleotide encoding DAHPS feedback insensitive and (b) regenerating the transformed cell into a transgenic plant comprising at least one cell having an altered content of at least one of shikimate, chorismate and an aromatic acid compared to a corresponding cell of a non transgenic plant.
Methods for transforming a plant cell with nucleic acids sequences according to the present invention are known in the art. As used herein the term “transformation” or “transforming” describes a process by which a foreign DNA, such as a DNA construct, enters and changes a recipient cell into a transformed, genetically modified or transgenic cell. Transformation may be stable, wherein the nucleic acid sequence is integrated into the plant genome and as such represents a stable and inherited trait, or transient, wherein the nucleic acid sequence is expressed by the cell transformed but is not integrated into the genome, and as such represents a transient trait. According to preferred embodiments the nucleic acid sequence of the present invention is stably transformed into a plant cell.
There are various methods of introducing foreign genes into both monocotyledonous and dicotyledonous plants (for example, Potrykus I. 1991. Annu Rev Plant Physiol Plant Mol Biol 42:205-225; Shimamoto K. et al., 1989. Nature 338:274-276).
The principal methods of the stable integration of exogenous DNA into plant genomic DNA includes two main approaches:
Agrobacterium-mediated gene transfer: The Agrobacterium-mediated system includes the use of plasmid vectors that contain defined DNA segments which integrate into the plant genomic DNA. Methods of inoculation of the plant tissue vary depending upon the plant species and the Agrobacterium delivery system. A widely used approach is the leaf-disc procedure, which can be performed with any tissue explant that provides a good source for initiation of whole-plant differentiation (Horsch et al., 1988. Plant Molecular Biology Manual A5, 1-9, Kluwer Academic Publishers, Dordrecht). A supplementary approach employs the Agrobacterium delivery system in combination with vacuum infiltration. The Agrobacterium system is especially useful in the generation of transgenic dicotyledenous plants.
Direct DNA uptake: There are various methods of direct DNA transfer into plant cells. In electroporation, the protoplasts are briefly exposed to a strong electric field, opening up mini-pores to allow DNA to enter. In microinjection, the DNA is mechanically injected directly into the cells using micropipettes. In microparticle bombardment, the DNA is adsorbed on microprojectiles such as magnesium sulfate crystals or tungsten particles, and the microprojectiles are physically accelerated into cells or plant tissues.
According to certain embodiments, transformation of the DNA constructs of the present invention into a plant cell is performed using Agrobacterium system.
The transgenic plant is then grown under conditions suitable for the expression of the recombinant DNA construct or constructs. Expression of the recombinant DNA construct or constructs alters the quantity of at least one of shikimate, chorismate and an aromatic acid of the transgenic plant compared to their quantity in a non transgenic plant.
The regeneration, development and cultivation of plants from single plant protoplast transformants or from various transformed explants is well known in the art (Weissbach and Weissbach, In.: Methods for Plant Molecular Biology, (Eds.), 1988 Academic Press, Inc., San Diego, Calif.). This regeneration and growth process typically includes the steps of selection of transformed cells, culturing those individualized cells through the usual stages of embryonic development through the rooted plantlet stage. Transgenic embryos and seeds are similarly regenerated. The resulting transgenic rooted shoots are thereafter planted in an appropriate plant growth medium such as soil.
Selection of transgenic plants transformed with a nucleic acid sequence of the present invention as to provide transgenic plants having altered amount of shikimate, chorsimate, aromatic amino acids and secondary metabolites derived therefrom is performed employing standard methods of molecular genetic, known to a person of ordinary skill in the art. According to certain embodiments, the nucleic acid sequence further comprises a nucleic acid sequence encoding a product conferring resistance to antibiotic, and thus transgenic plants are selected according to their resistance to the antibiotic. According to other embodiments, the antibiotic serving as a selectable marker is one of the aminoglycoside group consisting of paromomycin and kanamycin. According to additional embodiments, the nucleic acid sequence further comprises a nucleic acid sequence encoding a product conferring resistance to an herbicide, including, but not limited to, resistant to Glufosinate ammonium. According to yet further embodiments, the nucleic acid sequence further comprises a polynucleotide encoding at least one copy of the hemagglutinin (HA) epitope tag, operably linked to the polynucleotide encoding AroG DAHPS. According to certain currently preferred embodiments, the nucleic acid sequence comprises a polynucleotide encoding three copies of the hemagglutinin (HA) epitope. According to these embodiments, proteins are then extracted and transgenic plants are selected according to the protein extracts reacting with HA-epitope antibodies.
Extraction and detection of the metabolites synthesized by the transgenic plant cells can be performed by standard methods as are known to a person skilled in the art. According to certain embodiments, the metabolites of the present invention are extracted and analyzed by GC-MS as described by Mintz-Oron et al., 2008 (Plant Physiol 147(2):823-51), LC-MS and HPLC as described by Fraser et al. 2000 (Plant J 24(4):551-558) and as described in the Example section hereinbelow.
The development or regeneration of plants containing the foreign, exogenous gene that encodes a protein of interest is well known in the art. Preferably, the regenerated plants are self-pollinated to provide homozygous transgenic plants. Otherwise, pollen obtained from the regenerated plants is crossed to seed-grown plants of agronomically important lines, or pollen from plants of these important lines is used to pollinate regenerated plants. A transgenic plant of the present invention containing a desired polypeptide is cultivated using methods well known to one of skill in the art.
There is a variety of methods in the art for the regeneration of plants from plant tissue. The particular method of regeneration will depend on the starting plant tissue and the particular plant species to be regenerated.
Also within the scope of this invention are seeds or plant parts obtained from the transgenic plants. Plant parts include differentiated and undifferentiated tissues, including but not limited to, roots, stems, shoots, leaves, pollen, seeds, tumor tissue, and various forms of cells and culture such as single cells, protoplasts, embryos, and callus tissue. The plant tissue may be in plant or in organ, tissue or cell culture.
The following non-limiting examples hereinbelow describe the means and methods for producing the transgenic plants of the present invention. Unless stated otherwise in the Examples, all recombinant DNA and RNA techniques, as well as horticultural methods, are carried out according to standard protocols as known to a person with an ordinary skill in the art.
The coding DNA sequence of the E. coli AroG gene, encoding the DAHPS, was amplified by PCR with the following oligonucleotides: forward 5′ CATGCATGCTGATGAATTATCAGAACGACGA-3′ (SEQ ID NO:10) that introduces a SphI restriction site (underlined); and reverse 5′-GGAATTCCCCGCGACGCGCTTTTACTG-3′ (SEQ ID NO:11) that introduces an EcoRI restriction site (underlined). Two kinds of recombinant genes were constructed: AroGWT (the original sequence), encoding the feedback sensitive enzyme, and AroG175, having a point mutation at the 524 bp (leading to the replacement Leu175Glu), encoding the feedback insensitive enzyme. AroG175 was constructed using PCR with the following oligonucleotides: forward 5′-GTGCACCGCGAACAGGCATCAGGGCTT-3 (SEQ ID NO:12) and reverse 5′-AAGCCCTGATGCCTGTTCGCGGTGCAC-3′ (SEQ ID NO:13). The AroG209, having a point mutation at the 625-626 bp (leading to the replacement Phe209Ala), encoding the feedback insensitive enzyme. AroG209 was constructed using PCR with the following oligonucleotides: forward 5′-GCGCCGCACTGCGCCCTGTCCGTAACG-3 (SEQ ID NO:14) and reverse 5′-CGTTACGGACAGGGCGCAGTGCGGCGC-3′ (SEQ ID NO:15). The RuBisCO small subunit-3A plastid transit peptide (Shaul, O. and G. Galili. Plant Mol Biol, 1993. 23: p. 759-768) was fused in frame to the 5′ end of the AroG open reading frame. The AroG 3′ was fused to three copies of an HA epitope tag fused to an octopine synthase terminator. The chimeric gene and the vector were digested with the restriction enzymes NotI (BioLab) respectively and combined by T4 DNA ligase (BioLabs) and the entire fragment was sub-cloned into the Ti plasmid pBART, a derivative of pART27 (Gleave, A. P., Plant Mol Biol 1992. 20(6):1203-7). For sequence alignment, the NCBI database was used (http://www.ncbi.nlm.nih.gov). Agrobacterium tumefacies (A. tumefacies) strain EHA-105, was transformed with the plasmids by electrophoresis using gene pulser apparatus (Bio Rad).
Wild type (WT) Arabidopsis thaliana, ecotype Colombia plants were inoculated by submersing inflorescences in the transformed A. tumefacies culture as previously described (Clough, S. J. and A. F. Bent, 1998. Plant J 16(6):735-43).
Wild type tomato, ecotype M82 plants were inoculated by submersing cotyledon in the transformed A. tumefacies culture as previously described (McCormic S., Plant Tissue Manual. 1991. B6:109; Fillati, J. J. et al., 1987. Bio/Technology 5:726-730).
Arabidopsis seeds were collected dried, and sowed on soil. Young seedlings were selected for transgenic plants selection by spraying with Basta (Glufosinate ammonium; Bayer CropScience). Tomato seeds sterilized and sowed on Petri dishes containing Nitsch complete medium pH 6 (Duchefa, Haarlem, Netherlands) supplemented with 1% sucrose and 1% plant agar. For transgenic tomato plants selection, 50 μg/ml kanamycine was added to the growth medium. The seeds were imbibed for 48 h at 4° C. and transferred to a climate-controlled growth room with a regime of 16 h light/8 h dark (long day conditions) on 22° C.
T2 generation plants were measured for progeny test and lines with a single gene insertion were selected based on 3:1 genetic segregation. 5MT (Sigma/Aldrich) Trp analog resistance test was performed as previously described (Li J. and R. L. Last, 1996. Plant Physiol 110(1):51-59; Tzin V. et al., 2009. Plant Journal 60(1):156-167).
The resistant seedlings were removed to soil and grown in the greenhouse at 22° C. under long day conditions. For testing the response of plant growth to 5MT (Sigma/Aldrich), plant seeds homozygous for AroG175 and control plants were germinated on Nitsch medium as described above supplemented with 75, 100 or 150 μM of 5MT (Li and Last 1996, supra)
Western blot analysis was performed using anti-HA tag antibodies in order to identify the mutated plants which translated the chemeric gene (Stepansky, A. and G. Galili. Plant Physiol, 2003. 133(3): p. 1407-15). Additionally, T2 generation plants were measured for progeny test and lines with a single insertion gene were selected based on 3:1 genetic segregation.
Metabolic analysis was performed with aerial tissues of Arabidopsis seedlings (100 mg frozen powder) expressing the AroGWT and AroG175 and control lines (n=5-6). For UPLCqTOF-MS analysis, Arabidopsis samples were extracted in 450 μl of methanol 80%. Sample preparation and injection conditions were as previously described (Mintz-Oron, S. et al., Plant Physiol, 2008. 147(2):823-51). For GC-MS analysis, the seedlings were harvested, frozen, ground and extracted in 450 μl of methanol, 750 μl methanol, 750 μl water and 375 μl chloroform as previously described (Malitsky, S. et al., Plant Physiol, 2008. 148(4):2021-2049). To assess whether the different lines in the analysis vary in their composition of metabolites, Student's t-test (JMP software) was performed. The resulting P-values were controlled for multiple hypotheses testing using a 5% FDR cutoff (Hochberg Y. and Y. Benjamini 1990. Statistics in Medicine 9(7):811-818). The PCA plots were generated using the TMEV4 software (Saeed, A. I. et al., Biotechniques, 2003. 34(2):374-378; Scholz, M. et al., 2004. Bioinformatics, 20(15):2447-2454).
Non-targeted metabolic analysis was performed with three developing stages of tomato fruits (500 mg frozen powder) expressing the AroG175 and AroG209 and WT (n=5), extracted in 1.5 ml of methanol 100%. Sample preparation and injection conditions were performed as previously described (Mintz-Oron, S., et al. Plant Physiol, 2008. 147(2): p. 823-51).
The analysis of the raw UPLC-qTOF-MS data was performed using the XCMS software that performs chromatogram alignment, mass signal detection and peak integration (Smith, C. et al., Anal Chem, 2006. 78:779-787) from the Bioconductor package (v. 2.1) for the R statistical language (v. 2.6.1). XCMS was used with the following parameters: fwhm=10.8, step=0.05, steps=4, mzdiff=0.07, snthresh=8, max=1000. Injections of samples in the positive and negative ionization modes were performed in separate injection sets and pre-processing was done for each ionization mode independently. Differential mass ions were determined using a Student's 1-test (JMP software). The GC-MS analysis was performed as previously described (Malitsky, S. et al., Plant Physiol, 2008. 148(4):2021-2049), (n=5-6) The Xcalibur software v.1.4 (Thermo Finnigan; http://www.thermo.com/) was used for data analysis and compounds were identified by comparison of their retention index (R1) and mass spectrum to those generated for authentic standards analyzed on the same instrument. In cases when standards were not available, compounds were putatively identified by comparison of their R1 and mass spectrum to those present in the mass spectra library of Max-Planck-Institute for Plant Physiology, Golm, Germany (Q_MSRI_ID, http://csbdb.mpimp-golm.mpg.de/csbdb/gmd/msri/gmd msri.html) and the commercial mass spectra library NIST05 (www.nist.gov). The response values for metabolites resulting from the Xcalibur processing method were normalized to the ribitol internal standard. A Student's t-test analysis was done on metabolites level with significant changes in the two transformed AroG175 genotypes by using the JMP software. Then, the PCA plots were generated using the TMEV4 software (Saeed et al. 2003, supra; Scholz, et al. 2004, supra).
All experiments analyzing RNA expression levels were carried out using two replicates of aerial tissues of 10 days old Arabidopsis seedlings from plants grown under controlled environment conditions. Total RNA was extracted as previously described (Chomczynski P., 1993. Biotechniques 15(3):532-537) and treated with DNAase RQ-1 (Promega). RNA was then amplified using 1-cycle Affimetrix labeling using the standard Affymetrix protocol. Hybridization, labeling, scanning and data extraction were performed according to the standard Affymetrix protocols. Transcriptome analysis was carried out using Partek Genome Suite software (www.partek.com). Pre-processing was carried out using the Robust Microarray Averaging (RMA) algorithm (Irizarry R. A. et al., 2003. Biostatistics 4(2):249-264). One way ANOVA analysis was performed, fold change between lines was calculated (two fold) and FDR was applied to correct form multiple comparisons (Hochberg and Benjamini 1990, supra). Over-representation analysis was performed by PageMan tool (http://mapman.mpimp-golm.mpg.de/general/ora/ora.shtml) (Usadel B. et al., 2006. BMC Bioinformatics 7:535). Visualization of metabolic pathways and other functional categories was preformed with the MapMan software tool (Usadel B. et al., 2005. Plant Physiol 138(3):1195-1204.). Common locus number (AGI) was used from TAIR nomenclature (http://www.arabidopsis.org). For a two-step quantitative RT-PCR, a Platinum SYBR SuperMix (Invitrogen) RT-PCRs were tracked on an ABI 7300 instrument (Applied Biosystems). Each sample was amplified by PCR using the same amount of cDNA template in triplicate reactions as previously describe (Mintz-Oron et al. 2008, supra).
To study the importance of DAHPS in regulating fluxes bridging primary and secondary metabolism in plants, Arabidopsis plants were transformed with either a chimeric AroGWT or a chimeric AroG175 or AroG209 genes (
A global view of the effect of the expression of the AroGWT, AroG175 and AroG209 transgenes on plant metabolism was obtained by performing gas chromatograph-mass spectrometry (GC-MS) analysis of polar compounds of derivatized extracts. 20 days-old plants from four independently transformed plants of each genotypes (2-3 independent analyses from each genotype; each derived from extracts made from ˜7 plants) as well as WT plants (five independent analyses) were taken for the analysis. The data set was first analyzed by a Principal Component Analysis (PCA). In this analysis, the metabolic profiles of the control and AroGWT genotypes grouped together, and were completely separated from the AroG175 and AroG209 genotypes (
To test further whether AroGWT, AroG175 and AroG209 expression alters the levels of metabolites associated with the shikimate and aromatic amino acid biosynthesis pathways (
The effect of AroG175 expression on a wide range of primary and secondary metabolites was examined in two independently transformed homozygous AroG175 line, AroG175-2 and AroG175-21. These lines expressed either medium (AroG175-2) or relatively high (AroG175-21) level of the AroG175 polypeptide (
In the LC-MS analysis, the AroG175-2 line generally displayed milder changes in the levels of the different metabolites compared to the AroG175-21 line (data not shown). Thus, the non-targeted LC-MS analysis focused only on metabolites that their level was significantly different between the AroG175-21 line and the control, but also showed similar direction of change in the AroG175-2 line. The non-targeted LC-MS analysis of AroG175-21 line revealed a total of 4473 mass signals, of which the levels of 2414 were significantly altered (up or down regulated) as compared to the control. Assuming an average of five mass signals per single metabolite (Malitsky S. et al., 2008. Plant Physiology 148(4):2021-2049), AroG175 expression in the AroG175-21 line resulted in altered levels of ˜500 metabolites. In regard to the two other aromatic amino acids, this analysis showed that the level of tryptophan was 2.6-fold higher in the AroG175-21 line, compared to the control, while its level in the AroG175-2 line was not significantly different from the control (
The LC-MS analysis also showed that the level of a number of phenylalanine-derived phenylpropanoids secondary metabolites is significantly higher in AroG175-21 compared to the control plants (
Since tryptophan level was higher in the AroG175-21, but not in the AroG175-2, as compared to the control lines (
To study the importance of DAHPS in regulating fluxes bridging primary and secondary metabolism in plants, tomato plants were transformed with either a chimeric AroG175 or AroG209 genes (
At the first stage of studying the effect of expression of the AroG175 and AroG209 transgenes on plant metabolism, LC-MS analysis was performed for ripe tomato fruit from five independently transformed genotypes for each transgenic plants (5-6 independent analyses from each genotype; each derived from extracts made from ˜10 plants) as well as WT plants (five independent analyses). To get a global view on the metabolic effects of the AroG175 and AroG209 genotypes, the data set was first analyzed by a PCA plot. In this analysis, the metabolic profile of the control was completely separated from the AroG175 and AroG209 genotypes (
4.7
89.0
2.4
22.1
171.9
15.3
4.1
0.4
0.5
0.1
0.5
2.0
0.1
0.5
2.5
7.6
354.3
604.8
3.4
276.3
235.9
2.5
17.4
62.9
8.0
22.0
1.7
0.5
1.5
1.7
103.1
92.3
73.6
5.3
0.3
0.2
1.9
2.9
2.1
164.8
613.6
114.5
15.3
108.7
10.1
5.2
0.4
0.2
3.9
2.3
2.9
0.2
~0.001
0.1
~0.001
0.3
0.55
Metabolite levels are shown as fold change ±SE from five (UPLC-qTOF-MS analysis) or six (GC-MS analysis) or four (UPLC) independent samples in comparison with the WT. The metabolite levels are presented as fold change (AroG209-2/WT) in each developing stage. The three developing stages are: mature green (MG; ˜42 days post anthesis (DPA)), breaker (Br; ˜44 DPA) and red (red; ˜48 DPA) and separated to peel and flesh. P-values are shown as <0.05 (FDR). Terms in bold indicate a statistically significant increase as analyzed by two-way ANOVA and Student t-test. N.D. not detected.
The effect of AroG209 expression of T2 generation on a wide range of primary and secondary metabolites was examined on selected transformed homozygous AroG209-9 genotypes. This genotype contained a single insertion, based on PCR and antibiotic resistance. In order to study the effects of AroG209 expression on tomato fruit metabolism, tomato fruit in three developing stages were subjected to Lc-MA analysis: mature green (about 42 days post anthesis (DPA); breaker (about 44 DPA); and red (about 48 DPA). 5-6 independent analyses from AroG209 and WT genotypes at each developing stages were examined. Each analysis was derived from extracts made from three fruit collected from 10 plants. To get a global view on the metabolic effects of the AroG209 expression in tomato peel tissue, a PCA was performed of datasets obtained from 2,725 mass signals in negative ion mode. Interestingly, the mature green stage of both AroG209-9 and WT combine, a weak separation occurs in the breaker stage and a completely separation occurs in the red stage (
The effect of AroG175 expression on the global transcriptome of Arabidopsis was studied. A microarray analysis was performed with samples extracted from aerial tissues of 10 days old control and AroG175-2 seedlings, using the Affymetrix AtH1 GeneChip. The AroG175-2 line that was shown to have a moderate change in the metabolite was selected, to reduce the chance of pleiotropic effects. ANOVA analysis of the microarray results followed multiple hypotheses testing using a 5% FDR cutoff, indicated that expression of a relatively small number of genes (109 genes) showed a significant and at least 2-fold change between the control and AroG175-2 line, indicating a relatively moderate effect of AroG expression on the Arabidopsis transcriptome.
Genes that were consistently up-regulated (77 genes) and down-regulated (32 genes) were classified by over-representation analysis using the PageMan and MapMan software tools (http://mapman.mpimpgolm.mpg.de/general/ora/ora.shtml; (Usadel et al. 2006, supra). The major effects of the AroG125-2 gene included a stimulation of the expression of 37 genes associated with biotic stress (Tables 2 and 3).
The biotic stress category included genes associated with hormone metabolism (cytokinin, absicisic acid, salicylate and jasmonate), transcription factors (MYBs, WRKYs and APETALA2/Ethylene-responsive element binding proteins), signaling (calcium and cytokinin AAR-genes), pathogenesis (PR proteins), disease resistance (TIR-NB proteins), transporters and redox regulation. In addition, genes that putatively encode proteins associated with secondary metabolism were induced, including phenylprpanoid metabolism, Met-aliphatic-glucosinolates and a gene associated with Trp-derived indole-glucosinoltes. Another enriched category displaying increased expression was associated with nitrate assimilation. Notably, the expression level of 16 genes, categorized as genes associated with the circadian clock, was also induced in the AroG175-2 transcriptome. These circadian clock-related genes included those encoding MYB transcription factors, Zinc Finger B-box type proteins with a CCT DNA-binding domain and three other genes, encoding proteins associated with the circadian clock cascade including TOC1, Pseudo-response regulator and ELF4 (Early flowering 4). To corroborate the microarray results, a quantitative RT-PCR analysis was also performed on a representative sample of genes whose mRNA level was higher in the AroG175-2 than in the control line in the microarray analysis. This analysis, which was performed on both AroG175-2 and AroG175-21 lines, confirmed the gene expression results obtained by the microarray analysis.
A panel of 10 expert trained flavorists evaluated the aroma of fruit samples obtained from tomato plants expressing the AroG209-9 gene. Preliminary tests were carried out to improve the ability of the assessors to recognize odour defects and consistently quantify sensory properties. The panelists had previously been trained in the quantitative description of tomato attributes according to selection trials based on French norms (ISO8586-1, AFNOR V09-003). For each fruit sample, flavorists evaluated whole fruits for peel profiling and cut fruits—for the evaluation of flesh. Aroma evaluation was carried out by sniffing the samples by all panel members. Several attributes were chosen: acidic floral, fresh, green, metallic musty, ripe, spicy, and sweet in addition to global aroma intensity. Scores values were between 0 (none) to 5 (very strong). When completed, panel members discussed their scores and agreed on the final summarizing score of each aroma group. The results are summarized in
The foregoing description of the specific embodiments will so fully reveal the general nature of the invention that others can, by applying current knowledge, readily modify and/or adapt for various applications such specific embodiments without undue experimentation and without departing from the generic concept, and, therefore, such adaptations and modifications should and are intended to be comprehended within the meaning and range of equivalents of the disclosed embodiments. It is to be understood that the phraseology or terminology employed herein is for the purpose of description and not of limitation. The means, materials, and steps for carrying out various disclosed functions may take a variety of alternative forms without departing from the invention.
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/IL11/00535 | 7/6/2011 | WO | 00 | 1/4/2013 |
| Number | Date | Country | |
|---|---|---|---|
| 61361549 | Jul 2010 | US |
